Urgent Need to Fight Creationism

After years of studying the creation-evolution controversy, I  have no doubts about the religious intent of the  creationists. As Ayala, Gould and Gell-Mann suggest, creationists are simply using science to bolster their credibility as they seek to bring their religious theories to the public schools. In fact, this goal is made explicit in a creationist newsletter, which advises their vanguard to "sell more science. . . . Who can object to teaching more science?" Yet the creationists h

Written byDorothy Nelkin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After years of studying the creation-evolution controversy, I have no doubts about the religious intent of the creationists. As Ayala, Gould and Gell-Mann suggest, creationists are simply using science to bolster their credibility as they seek to bring their religious theories to the public schools. In fact, this goal is made explicit in a creationist newsletter, which advises their vanguard to "sell more science. . . . Who can object to teaching more science?" Yet the creationists have done little to develop the empirical evidence needed to support their so-called science. For them, the Bible is sufficient.

Creationists have influenced teachers, school boards and textbook publishers because there is considerable public support for their demands. According to surveys, most Americans believe that both the scientific theory of evolution and the biblical theory of creation should be taught in public schools. In the United States, citizens assume that democratic notions of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies